Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T79473
|
||||
Former ID |
TTDS00254
|
||||
Target Name |
Lutropin-choriogonadotropic hormone receptor
|
||||
Gene Name |
LHCGR
|
||||
Synonyms |
LH/CG-R; LHR; LHRH receptor; LSH-R; Luteinizing hormone receptor; Luteinizing hormone-releasing hormone receptor; LHCGR
|
||||
Target Type |
Successful
|
||||
Disease | Breast cancer [ICD9: 174, 175; ICD10: C50] | ||||
Cancer [ICD9: 140-229; ICD10: C00-C96] | |||||
Female infertility [ICD9: 628; ICD10: N97.0] | |||||
Fertility [ICD10: N00-N99] | |||||
Heart disease [ICD9: 390-429; ICD10: I00-I52] | |||||
Infertility [ICD9: 628; ICD10: N97.0] | |||||
Leukemia [ICD9: 208.9; ICD10: C90-C95] | |||||
Myelodysplastic syndrome [ICD9: 238.7; ICD10: D46] | |||||
Function |
Receptor for lutropin-choriogonadotropic hormone. The activity of this receptor is mediated by G proteins which activate adenylate cyclase.
|
||||
BioChemical Class |
GPCR rhodopsin
|
||||
UniProt ID | |||||
Sequence |
MKQRFSALQLLKLLLLLQPPLPRALREALCPEPCNCVPDGALRCPGPTAGLTRLSLAYLP
VKVIPSQAFRGLNEVIKIEISQIDSLERIEANAFDNLLNLSEILIQNTKNLRYIEPGAFI NLPRLKYLSICNTGIRKFPDVTKVFSSESNFILEICDNLHITTIPGNAFQGMNNESVTLK LYGNGFEEVQSHAFNGTTLTSLELKENVHLEKMHNGAFRGATGPKTLDISSTKLQALPSY GLESIQRLIATSSYSLKKLPSRETFVNLLEATLTYPSHCCAFRNLPTKEQNFSHSISENF SKQCESTVRKVNNKTLYSSMLAESELSGWDYEYGFCLPKTPRCAPEPDAFNPCEDIMGYD FLRVLIWLINILAIMGNMTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDS QTKGQYYNHAIDWQTGSGCSTAGFFTVFASELSVYTLTVITLERWHTITYAIHLDQKLRL RHAILIMLGGWLFSSLIAMLPLVGVSNYMKVSICFPMDVETTLSQVYILTILILNVVAFF IICACYIKIYFAVRNPELMATNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLIT VTNSKVLLVLFYPINSCANPFLYAIFTKTFQRDFFLLLSKFGCCKRRAELYRRKDFSAYT SNCKNGFTGSNKPSQSTLKLSTLHCQGTALLDKTRYTEC |
||||
Drugs and Mode of Action | |||||
Drug(s) | Choriogonadotropin alfa | Drug Info | Approved | Female infertility | [536361] |
Gonadotropin, Chorionic | Drug Info | Approved | Fertility | [551871] | |
Lutropin alfa | Drug Info | Approved | Female infertility | [536361] | |
ML-04 | Drug Info | Phase 2 | Myelodysplastic syndrome | [521530] | |
Org-43902 | Drug Info | Phase 1 | Infertility | [549583] | |
LDI-200 | Drug Info | Discontinued in Phase 3 | Leukemia | [546170] | |
Human chorionic gonadotropin | Drug Info | Terminated | Heart disease | [538686], [546721] | |
Modulator | Choriogonadotropin alfa | Drug Info | [556264] | ||
EP-200 | Drug Info | [543644] | |||
Gonadotropin, Chorionic | Drug Info | [556264] | |||
LDI-200 | Drug Info | [543644] | |||
ML-04 | Drug Info | [528609] | |||
Inhibitor | Human chorionic gonadotropin | Drug Info | [543644] | ||
Agonist | Labeled LH superagonist | Drug Info | [543644] | ||
LH superagonists | Drug Info | [543644] | |||
Org-43902 | Drug Info | [532276] | |||
Binder | Lutropin alfa | Drug Info | [536778] | ||
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM) | |||||
TEP | EXP Info | ||||
Pathways | |||||
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Ovarian steroidogenesis | |||||
Prolactin signaling pathway | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
Pathway Interaction Database | Arf6 signaling events | ||||
PathWhiz Pathway | Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin | ||||
Reactome | Hormone ligand-binding receptors | ||||
G alpha (s) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Ovarian Infertility Genes | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
Ref 521530 | ClinicalTrials.gov (NCT00044226) A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).. U.S. National Institutes of Health. | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 538686 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1160). | ||||
Ref 546170 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006739) | ||||
Ref 546721 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009926) | ||||
Ref 528609 | Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. Nucl Med Biol. 2007 Jan;34(1):55-70. | ||||
Ref 532276 | First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive age. J Clin Endocrinol Metab. 2013 Apr;98(4):1558-66. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.